Error: Could not add to watchlist. X
+ Watchlist

Paratek Pharmaceuticals Inc

TSPT:US
Ticker Change
TSPT:US has changed to a new ticker symbol
USD
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (USD)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.53%
% Price Change
+0.52%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Paratek Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the development and commercialization of antibiotics. The Company develops medicine for serious community-acquired bacterial infections. Paratek Pharmaceuticals products treat patients in both the community and hospital setting.
Address
75 Park Plaza
4th Floor
Boston, MA 02116
United States
Phone
1-617-807-6600
  • Michael F Bigham
    Chairman/CEO
  • Evan Loh
    President/COO/Chief Medical Ofcr
  • Douglas W Pagan
    Chief Financial Officer
  • William M Haskel "Bill"
    Senior VP/Secy/General Counsel
  • Evan Tzanis
    Senior VP:Clinical Development
Show More